UK Anti-Doping, the national anti-doping organisation for the UK, has today welcomed the announcement by the Canadian Centre for Ethics in Sport (CCES) that an athlete has been sanctioned for an adverse analytical finding for human growth hormone (hGH).
This first finding and sanction of its kind in North America follows the analytical positive for hGH by UK Anti-Doping in February this year, and signals another positive milestone in the global fight against doping in sport.
UK Anti-Doping Chief Executive Andy Parkinson said: “The announcement by our colleagues at the CCES is further evidence of the rate at which the ability to analyse prohibited substances is advancing on a worldwide scale. As recently as only January, any athlete contemplating doping with hGH will probably have been confident of evading sanction. This case further reinforces the message that the use of hGH can now be detected and anyone thinking of going down that path should think again.”
For more information on the finding, please visit the CCES website at www.cces.ca